The larger news organizations will pick it up over the weekend. It will probably be posted as AVII news monday. That little newspaper is very close to AVII and probably gets a quick look at everything. I am sure the Oregonian will pick up and it will hit the AP wires.
...demand would be limited. But if AVI can show "proof of concept" for its antisense platform, the potential market for treating other ailments is enormous. =================== Enormous. The potential markets would be enormous.
I have my shares of AVII and I'm feeling really good about it.
Hello, Article: According to the CDC, there are only two other clinical trials under way in this country for West Nile treatments. One is testing a form of interferon, .............
THIS COMPANY COULD BE HEMISPHERX (HEB)
It also seems to profit from Westnile Virus
Alferon N Injection� is the company�s registered trademark for it�s injectible formulation or natural alpha interferon approved by the FDA for the treatment of genital HPV (refractory condylomata acuminata). Alferon N Injection� is also targeted at Hepatitis C, HIV, West Nile Virus, and SARS